Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 9Leukemia 9Congenital Abnormalities 8Myelodysplastic Syndromes 5Leukemia, Myelomonocytic, Chronic 5Leukemia, Myeloid, Chronic-Phase 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Myeloproliferative Disorders 4Leukemia, Monocytic, Acute 4Leukemia, Megakaryoblastic, Acute 4Leukemia, Erythroblastic, Acute 4Anemia, Refractory, with Excess of Blasts 4Thrombocythemia, Essential 3Polycythemia Vera 3Leukemia, Myelomonocytic, Acute 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Leukemia, Lymphocytic, Chronic, B-Cell 3Blast Crisis 3Primary Myelofibrosis 2Multiple Myeloma 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Myeloid, Accelerated Phase 2Chromosome 5q Deletion Syndrome 2Breast Neoplasms 2Waldenstrom Macroglobulinemia 1Unspecified Adult Solid Tumor, Protocol Specific 1

Interventions

fludarabine phosphate 18Cyclophosphamide 18Peripheral Blood Stem Cell Transplantation 17Busulfan 17Tacrolimus 14Methotrexate 14Mycophenolic Acid 12Antilymphocyte Serum 12Cyclosporine 11Whole-Body Irradiation 9Filgrastim 7Etoposide 7Radiotherapy 6Methylprednisolone 6Melphalan 6Flow Cytometry 6Cord Blood Stem Cell Transplantation 6Therapeutics 4Sirolimus 4Psychiatric Rehabilitation 4thymoglobulin 3Rituximab 3Polymerase Chain Reaction 3Ondansetron 3Immunologic Techniques 3Early Intervention, Educational 3Cytarabine 3Cyclosporins 3Aprepitant 3Alemtuzumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Pdgfra-Associated Chronic Eosinophilic Leukemia × Cytogenetic Analysis × Clear all
NCT00816413 2023-08-14

Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer

University of Nebraska

Phase 1/2 Withdrawn
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Anemia, Aplastic, Blast Crisis, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neoplasms, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡